Wiessner C, Allegrini P R, Rupalla K, Sauer D, Oltersdorf T, McGregor A L, Bischoff S, Böttiger B W, van der Putten H
Novartis Pharma AG, Basle, Switzerland.
Neurosci Lett. 1999 Jun 25;268(3):119-22. doi: 10.1016/s0304-3940(99)00392-4.
Protective effects after focal cerebral ischemia were assessed in transgenic mice that overexpress in a neuron-specific fashion mouse Bcl-XL or human Bcl-2. Both Bcl genes were under the control of the same mouse Thy-1 regulatory sequences resulting in very similar expression patterns in cortical neurons. Furthermore, these sequences direct lateonset (i.e. around birth) expression in brain, thus minimizing effects of transgene expression during brain development. Effects on infarct volume were measured using MRI after permanent occlusion of the middle cerebral artery (MCA). When compared to their non-transgenic littermates, Thy1mbcl-XL mice showed a significant 21% reduction in infarct size whereas Thy1hbcl-2 mice did not reveal any reduction. These findings suggest a selective protective advantage of Bcl-XL as compared with Bcl-2 in this mouse model for human stroke.
在以神经元特异性方式过表达小鼠Bcl-XL或人Bcl-2的转基因小鼠中评估局灶性脑缺血后的保护作用。两种Bcl基因均受相同的小鼠Thy-1调控序列控制,在皮质神经元中产生非常相似的表达模式。此外,这些序列指导大脑中晚期(即出生前后)的表达,从而将转基因表达对大脑发育的影响降至最低。在大脑中动脉(MCA)永久性闭塞后,使用MRI测量对梗死体积的影响。与它们的非转基因同窝小鼠相比,Thy1mbcl-XL小鼠的梗死面积显著减少了21%,而Thy1hbcl-2小鼠未显示出任何减少。这些发现表明,在这种人类中风小鼠模型中,与Bcl-2相比,Bcl-XL具有选择性保护优势。